In Vitro Efficacy of Antivenom and Varespladib in Neutralising Chinese Russell's Viper (Daboia siamensis) Venom Toxicity

Toxins (Basel). 2023 Jan 11;15(1):62. doi: 10.3390/toxins15010062.

Abstract

The venom of the Russell's viper (Daboia siamensis) contains neurotoxic and myotoxic phospholipase A2 toxins which can cause irreversible damage to motor nerve terminals. Due to the time delay between envenoming and antivenom administration, antivenoms may have limited efficacy against some of these venom components. Hence, there is a need for adjunct treatments to circumvent these limitations. In this study, we examined the efficacy of Chinese D. siamensis antivenom alone, and in combination with a PLA2 inhibitor, Varespladib, in reversing the in vitro neuromuscular blockade in the chick biventer cervicis nerve-muscle preparation. Pre-synaptic neurotoxicity and myotoxicity were not reversed by the addition of Chinese D. siamensis antivenom 30 or 60 min after venom (10 µg/mL). The prior addition of Varespladib prevented the neurotoxic and myotoxic activity of venom (10 µg/mL) and was also able to prevent further reductions in neuromuscular block and muscle twitches when added 60 min after venom. The addition of the combination of Varespladib and antivenom 60 min after venom failed to produce further improvements than Varespladib alone. This demonstrates that the window of time in which antivenom remains effective is relatively short compared to Varespladib and small-molecule inhibitors may be effective in abrogating some activities of Chinese D. siamensis venom.

Keywords: Daboia siamensis; Russell’s viper; Varespladib; antivenom; myotoxicity; neurotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antivenins / pharmacology
  • Daboia*
  • Neurotoxicity Syndromes* / drug therapy
  • Neurotoxicity Syndromes* / etiology
  • Snake Bites* / drug therapy
  • Viper Venoms / toxicity

Substances

  • Antivenins
  • varespladib
  • Viper Venoms

Grants and funding

This study was supported by an Australian National Health and Medical Research Council (NHMRC) Senior Research Fellowship (ID: 1154503) awarded to G.K.I., a NHMRC Centres for Research Excellence Grant (ID:1110343) awarded to G.K.I. and W.C.H., a 2021 Guangzhou Science and Technology Program City and University (Hospital) joint funded Grant (ID: 202102010282) and a 2022 General project Grant of Natural Science Foundation of Guangdong basic and applied basic research foundation (ID:2022A1515012095) awarded to Q.L.